Tag: validation

FDA Grants Orphan Drug Designation to SENTI-202 in AML

The biotechnology landscape is undergoing a seismic shift, with a new generation of therapies promising to redefine our approach to even the most challenging diseases. Leading this charge is SENTI-202, a groundbreaking CAR NK-cell therapy developed by Senti Biosciences, which recently received FDA orphan drug designation for the treatment of relapsed/refractory acute myeloid leukemia (R/R […]

Advancements in RNA Diagnostics for Precision Medicine in Immunotherapy

In a groundbreaking presentation at the RNA Society’s 30th Annual Meeting, Cofactor Genomics showcased their innovative work merging RNA analysis with artificial intelligence to revolutionize precision medicine in immunotherapy. The latest validation results for OncoPrism®, Cofactor’s cutting-edge RNA diagnostic tool, were unveiled, demonstrating the potential for personalized treatment strategies in cancer therapy. By harnessing the […]